CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
CYNA was delisted on the 20th of October, 2016.
32 hedge funds and large institutions have $116M invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
37% more capital invested
Capital invested by funds: $85.2M → $116M (+$31.3M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
3% more funds holding
Funds holding: 31 → 32 (+1)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$3.77M |
| 2 |
NC
Nexthera Capital
New York
|
+$2.83M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.28M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.62M |
| 5 |
DM
Deerfield Management
New York
|
+$657K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$6.39M |
| 2 |
Millennium Management
New York
|
-$2.57M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$1.8M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$650K |
| 5 |
CC
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
-$476K |
CYNA Hedge Fund Activity: Q2 2016 in Review
32 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q2 2016, worth a combined $116M — up 37% from $85.2M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CYNA positions and 4 closed out — a net gain of 1 holder — while 8 added to existing stakes and 9 trimmed.
The largest buyer was Tekla Capital Management, adding an estimated $3.77M. The largest seller was Acuta Capital Partners, cutting an estimated $6.39M.
- 32 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q2 2016, up from 31 in Q1 2016.
- Funds reported $116M of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q2 2016, up 37% quarter-over-quarter.
- 5 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q2 2016 and 4 closed out, a net change of +1 holder.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) buyer in Q2 2016 was Tekla Capital Management, an estimated $3.77M added.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q2 2016 was Acuta Capital Partners, an estimated $6.39M sold.
Based on aggregated 13F filings for Q2 2016.